Prevalence of potentially inappropriate medication use in older adults using the 2012 Beers criteria

Journal of the American Geriatrics Society
Amy J DavidoffDonna M Fick

Abstract

To use the most recently available population-based data to estimate potentially inappropriate medication (PIM) prevalence under the 2012 update of the Beers list of PIMs and to provide a benchmark from which to measure future changes. Retrospective cohort study using nationally representative data. 2006-2010 Medical Expenditure Panel Survey (MEPS). Community-dwelling sample of U.S. older adults (N=18,475). The updated Beers criteria were operationalized, generating a "broad" PIM definition that incorporated form, route, or dose restrictions where clearly specified and a "qualified" definition that applied specific exceptions where mentioned in the rationale associated with each drug category. Bivariate analyses described PIM prevalence, comparing the two operational definitions, and examined time trends. Of older adults with prescription medications, 42.6% had at least one medication fill that met the broad definition, with nonsteroidal anti-inflammatory drugs (NSAIDs) having the highest prevalence (10.9%). The rate declined from 45.5% in 2006-2007 to 40.8% in 2009-2010. The categories with the largest absolute decline were NSAIDs, selected sulfonylureas, and estrogens. PIM prevalence was 30.9% using the qualified definition. ...Continue Reading

References

Aug 1, 1993·Journal of the American Geriatrics Society·M H BeersJ C Beck
Feb 11, 2004·Archives of Internal Medicine·Margie Rauch Goulding
Nov 24, 2004·The American Journal of Geriatric Pharmacotherapy·Bruce StuartNancy Friedley
Jan 20, 2007·Journal of the American Geriatrics Society·Joseph V AgostiniSharon K Inouye
Feb 22, 2007·The Annals of Pharmacotherapy·Elda Jano, Rajender R Aparasu
Jan 1, 2008·Research in Nursing & Health·Donna M FickJennifer L Waller
Mar 2, 2011·The American Journal of Geriatric Pharmacotherapy·Seema D DedhiyaJoseph Thomas
Mar 10, 2011·Age and Ageing·Yan-Jun ZhangJeff J Guo
Oct 7, 2011·Journal of General Internal Medicine·Yuhua BaoMartha L Bruce
Nov 5, 2011·Journal of the American Medical Informatics Association : JAMIA·Richard T GriffeyDavid W Bates
Jan 13, 2012·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Steven C HillMarc W Zodet
Mar 2, 2012·Journal of the American Geriatrics Society·UNKNOWN American Geriatrics Society 2012 Beers Criteria Update Expert Panel
Jul 25, 2013·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Carolyn M Clancy
Oct 15, 2013·Journal of the American Geriatrics Society·Abir O KanaanJerry H Gurwitz
Dec 3, 2013·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Alain KoyamaKristine Yaffe

❮ Previous
Next ❯

Citations

Oct 9, 2015·Journal of the American Geriatrics Society·Michael A SteinmanPaul Mulhausen
Jan 26, 2016·Journal of the American Medical Directors Association·Anna-Liisa JuolaKaisu H Pitkälä
Dec 23, 2015·Drugs -- Real World Outcomes·Hee-Jin HwangKang Soo Lee
Mar 18, 2016·The New England Journal of Medicine·Tobias DreischulteBruce Guthrie
Oct 9, 2015·Journal of the American Geriatrics Society·UNKNOWN By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel
Apr 23, 2016·Journal of the American Geriatrics Society·Marcela JirónTil Stürmer
Oct 1, 2016·Health Services Research·G Edward MillerDonna M Fick
Apr 4, 2017·Geriatrics & Gerontology International·Fumihiro MizokamiKatsunori Furuta
Apr 12, 2017·Journal of Gerontological Nursing·Marcia Y ShadeBernice Yates
Jan 8, 2017·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Gregory CastelliDana King
Oct 14, 2017·Expert Opinion on Drug Safety·Davide SeripaFrancesco Panza
Sep 25, 2017·Journal of the American Geriatrics Society·Pierre Olivier LangRichard Aspinall
Dec 25, 2019·Journal of Clinical Pharmacy and Therapeutics·Andrew D BaumgartnerRanjit Singh
Oct 1, 2020·Journal of Managed Care & Specialty Pharmacy·Chanadda ChinthammitWei-Hsuan Lo-Ciganic
Dec 29, 2019·Journal of Evaluation in Clinical Practice·Tatiane C MarquesDivaldo P de Lyra-Jr
Feb 15, 2020·Aging Clinical and Experimental Research·Ali PourmandMaryann Mazer-Amirshahi
Aug 7, 2020·Journal of the American Geriatrics Society·Collin M ClarkDavid M Jacobs
Oct 4, 2017·Pharmacy : Journal of Pharmacy, Education and Practice·Nathan J PaulyJoshua D Brown
Jul 2, 2017·British Journal of Clinical Pharmacology·Stefan VargaVittorio Maio
Aug 27, 2019·Journal of Pharmacy Practice·Addison P RaganAnna Mirk
Nov 7, 2019·European Journal of Clinical Pharmacology·Jérôme Nguyen-SoenenJean-Pascal Fournier
Feb 19, 2020·The Nurse Practitioner·Kristene Diggins
Jun 21, 2017·Journal of Aging Research·Mohsen BazarganGail Orum
Jul 27, 2017·BMC Geriatrics·Mohsen BazarganGail Orum
Oct 6, 2017·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jennifer L LundTil Stürmer
Nov 26, 2020·Journal of Clinical Medicine·Jordan GuillotJulien Bezin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.